If, however, we bring together evidence indicating that the serum concentrations of the cytokine IL-37 rise in parallel to the level of insulin resistance and our results obtained by the six-cluster model, we can gain some further insights into associations between the phases of chronic inflammation and the progression rates of end-organ damage in patients with DM2 [34]. The gene discussed is IL37; the disease is Insulin resistance.